Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,700 | $2,207 | $2,342 | $2,749 |
| - Cash | $183 | $201 | $210 | $221 |
| + Debt | $76 | $78 | $80 | $83 |
| Enterprise Value | $1,593 | $2,084 | $2,212 | $2,610 |
| Revenue | $99 | $96 | $93 | $89 |
| % Growth | 3.1% | 3.5% | 4.6% | – |
| Gross Profit | $51 | $51 | $46 | $43 |
| % Margin | 51.3% | 53.4% | 49.6% | 48.3% |
| EBITDA | -$21 | $26 | -$33 | -$25 |
| % Margin | -21.1% | 27.5% | -35.1% | -28.3% |
| Net Income | -$27 | $20 | -$39 | -$32 |
| % Margin | -27.4% | 21.2% | -42.4% | -35.6% |
| EPS Diluted | -0.45 | 0.33 | -0.66 | -0.53 |
| % Growth | -236.4% | 150% | -24.5% | – |
| Operating Cash Flow | -$12 | -$1 | -$13 | -$21 |
| Capital Expenditures | -$12 | -$9 | -$4 | -$2 |
| Free Cash Flow | -$24 | -$11 | -$17 | -$24 |